Condition: Chronic Kidney Diseases · Sponsor: Centre Hospitalier Régional d'Orléans
This is a comparative, prospective, non-interventional study to evaluate immune response in patients with chronic kidney disease. The primary objective is to define immunodeficiency (phenotype and function of T cells) in patients with end-stage kidney disease. The second objective is to provide an in-vitro proof-of-concept of T-cell engineering in the context of end-stage kidney disease. The study population was patients with chronic kidney disease.
This description comes directly from the study's public registry record.
Manon DEKEYSER, PhD · +33238229870 · manon.dekeyser@chu-orleans.fr
Always discuss trial participation with your own doctor first.
| Center Hospitalier Universitaire d'Orléans | Orléans, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06474169